BlackBoxRX
 
We highly recommend enabling Javascript while using the BlackBoxRX site.

Teniposide

Myelosuppression; Hypersensitivity Reactions

Experienced Physician/Equipped Facilities

  • Teniposide injection) is a cytotoxic drug which should be administered under the supervision of a qualified physician experienced in the use of cancer chemotherapeutic agents.
  • Appropriate management of therapy and complications is possible only when adequate treatment facilities are readily available.
  • Severe myelosuppression with resulting infection or bleeding may occur.
  • Hypersensitivity reactions, including anaphylaxis-like symptoms, may occur with initial dosing or at repeated exposure to teniposide.
  • Epinephrine, with or without corticosteroids and antihistamines, has been employed to alleviate hypersensitivity reaction symptoms.

MONITORING RECOMMENDATIONS RELATED TO BLACK BOX DATA

  • Epinephrine with or without corticosteroids and antihistamines have been used to alleviate hypersensitivity reaction symptoms.
  • Perform baseline and periodic complete blood cell counts and assessments of renal and hepatic function during therapy.

Package Inserts

Teniposide

Additional Information

Updated January 2018